• Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort 

      Panopoulos S., Chatzidionysiou K., Tektonidou M.G., Bournia V.K., Drosos A.A., Liossis S.-N.C., Dimitroulas T., Sakkas L., Boumpas D., Voulgari P.V., Daoussis D., Thomas K., Georgiopoulos G., Vosvotekas G., Garyfallos A., Sidiropoulos P., Bertsias G., Vassilopoulos D., Sfikakis P.P. (2020)
      Background: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc's optimal management. Herein, we describe current treatment modalities and drug survival ...